The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding the molecular landscape of rare tumors through the CCDI-COG Molecular Characterization Initiative.
 
Lauren Vasta
No Relationships to Disclose
 
Jin Piao
No Relationships to Disclose
 
Kenneth Chen
No Relationships to Disclose
 
John Hicks
No Relationships to Disclose
 
Erin Rudzinski
No Relationships to Disclose
 
Kareesma Parbhoo
No Relationships to Disclose
 
John Shern
No Relationships to Disclose
 
Subhashini Jagu
Patents, Royalties, Other Intellectual Property - Richard Roden and Subhashini Jagu (2007): “Multitype HPV Peptide Compositions and Method for Treatment or Prevention of Human Papillomavirus Infection”.
 
Gregory Reaman
No Relationships to Disclose
 
Malcolm Smith
No Relationships to Disclose
 
Catherine Cottrell
No Relationships to Disclose
 
Douglas Hawkins
Research Funding - Bayer Health (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Pfizer (Inst)
 
Kris Ann Schultz
No Relationships to Disclose
 
Theodore Laetsch
Stock and Other Ownership Interests - Advanced Microbubbles
Consulting or Advisory Role - AI Therapeutics; Bayer; GlaxoSmithKline; ITM Oncologics; Jazz Pharmaceuticals
Research Funding - Adaptimmune (Inst); Advanced Accelerator Applications/Novartis (Inst); Bayer (Inst); BioAtla (Inst); Exelixis (Inst); ITM Oncologics (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Taiho Oncology (Inst); Turning Point Therapeutics (Inst)